Access is not theoretical. It is personal.

For more than twenty years, I built and led U.S. commercialization and market access strategy across rare disease, oncology, hematology, and gene therapy at companies including Vertex Pharmaceuticals, GlaxoSmithKline, and Johnson & Johnson. My work centered on one core question: Can patients actually access the innovation we develop?

Mental health advocacy has shaped my life since shortly after the birth of my first child. What began as a mother learning to navigate early warning signs grew into years of advocating within schools, healthcare systems, and insurance structures.

My support for the LGBTQIA+ community has been equally longstanding. In 2019, that commitment became personal when my son came out as transgender. My role shifted from ally to parent advocate, ensuring his identity was respected and affirmed in every space he entered.

In 2025, I stepped away from my professional life to concentrate on my personal one. As the primary income earner, it was a defining decision, and it was also the right one. During that time, I wrote Fighting for Their Lives, a memoir about resilience, identity, mental health systems, and what it means to fight for your child when institutions fail.

Long before any of this, I was a Division I basketball player. The court taught me how to pivot when the play breaks down, how to lose without losing myself, and how to move a team forward when the game gets hard. I’m still doing all of those things. Just on a different court now.